Publications by authors named "Andrew Galgoci"

Claim this Profile
I
Ibrexafungerp: An orally active β-1,3-glucan synthesis inhibitor.
James M Apgar, Robert R Wilkening, Dann L Parker, Dongfang Meng, Kenneth J Wildonger, Andrew M Galgoci

Bioorg Med Chem Lett· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MK-5204: An orally active β-1,3-glucan synthesis inhibitor.
James M Apgar, Robert R Wilkening, Dann L Parker, Dongfang Meng, Kenneth J Wildonger, Andrew M Galgoci

Bioorg Med Chem Lett· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Efficacy of Relebactam (MK-7655) in Combination with Imipenem-Cilastatin in Murine Infection Models.
Mary Ann Powles, Andrew Galgoci, Andrew Misura, Lawrence Colwell, Karen H Dingley

Antimicrob Agents Chemother· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dual-Targeting Small-Molecule Inhibitors of the Staphylococcus aureus FMN Riboswitch Disrupt Riboflavin Homeostasis in an Infectious Setting.
Hao Wang, Paul A Mann, Li Xiao, Charles Gill, Andrew M Galgoci

Cell Chem Biol· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel orally active inhibitors of β-1,3-glucan synthesis derived from enfumafungin.
James M Apgar, Robert R Wilkening, Mark L Greenlee, James M Balkovec, Amy M Flattery, Andrew M Galgoci

Bioorg Med Chem Lett· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Selective small-molecule inhibition of an RNA structural element.
John A Howe, Hao Wang, Thierry O Fischmann, Carl J Balibar, Li Xiao, Andrew M Galgoci

Nature· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Broadening the spectrum of β-lactam antibiotics through inhibition of signal peptidase type I.
Alex G Therien, Joann L Huber, Kenneth E Wilson, Patrick Beaulieu, Alexandre Caron, Andrew M Galgoci

Antimicrob Agents Chemother· September 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of caspofungin in a juvenile mouse model of central nervous system candidiasis.
Amy M Flattery, Emily Hickey, Charles J Gill, Mary Ann Powles, Andrew S Misura, Andrew M Galgoci

Antimicrob Agents Chemother· July 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of platencin, a dual FabF and FabH inhibitor with in vivo antibiotic properties.
Jun Wang, Srinivas Kodali, Sang Ho Lee, Andrew Galgoci, Ronald Painter

Proc Natl Acad Sci U S A· May 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Platensimycin is a selective FabF inhibitor with potent antibiotic properties.
Jun Wang, Stephen M Soisson, Katherine Young, Wesley Shoop, Srinivas Kodali, Andrew Galgoci

Nature· May 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of bacterial fatty acid synthase inhibitors from a Phoma species as antimicrobial agents using a new antisense-based strategy.
John G Ondeyka, Deborah L Zink, Katherine Young, Ronald Painter, Srinivas Kodali, Andrew Galgoci

J Nat Prod· March 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of FabH/FabF inhibitors from natural products.
Katherine Young, Hiranthi Jayasuriya, John G Ondeyka, Kithsiri Herath, Chaowei Zhang, Andrew Galgoci

Antimicrob Agents Chemother· February 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anthrabenzoxocinones from Streptomyces sp. as liver X receptor ligands and antibacterial agents.
Kithsiri B Herath, Hiranthi Jayasuriya, Ziqiang Guan, Marvin Schulman, Carolyn Ruby, Andrew Galgoci

J Nat Prod· September 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Determination of selectivity and efficacy of fatty acid synthesis inhibitors.
Srinivas Kodali, Andrew Galgoci, Katherine Young, Ronald Painter, Lynn L Silver

J Biol Chem· January 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of a small molecule that inhibits cell division by blocking FtsZ, a novel therapeutic target of antibiotics.
Jun Wang, Andrew Galgoci, Srinivas Kodali, Kithsiri B Herath, Hiranthi Jayasuriya

J Biol Chem· November 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis